<table id="table-1" width="100%" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1. Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets</caption>
<col align="center" width="40%"></col>
<col align="center" width="20%"></col>
<col align="center" width="20%"></col>
<col align="center" width="20%"></col>
<thead>
<tr><th stylecode="Lrule">Subject Groups: Metformin hydrochloride tablets dose<footnote>All doses given fasting except the first 18 doses of the multiple dose studies</footnote> (number of subjects)</th><th stylecode="Lrule">C<sub>max</sub><footnote>Peak plasma concentration</footnote><br/>(µg/mL)</th><th stylecode="Lrule">T<sub>max</sub><footnote>Time to peak plasma concentration</footnote><br/>(hrs)</th><th stylecode="Lrule Rrule">Renal Clearance<br/>(mL/min)</th></tr>
</thead>
<tbody>
<tr><td stylecode="Lrule"><content stylecode="bold">Healthy, nondiabetic adults:</content></td><td stylecode="Lrule"></td><td stylecode="Lrule"></td><td stylecode="Lrule Rrule"></td></tr>
<tr><td stylecode="Lrule">500 mg single dose (24)</td><td stylecode="Lrule">1.03 (±0.33)</td><td stylecode="Lrule">2.75 (±0.81)</td><td stylecode="Lrule Rrule">600 (±132)</td></tr>
<tr><td stylecode="Lrule">850 mg single dose (74)<footnote>Combined results (average means) of five studies: mean age 32 years (range 23-59 years)</footnote></td><td stylecode="Lrule">1.60 (±0.38)</td><td stylecode="Lrule">2.64 (±0.82)</td><td stylecode="Lrule Rrule">552 (±139)</td></tr>
<tr stylecode="Botrule"><td stylecode="Lrule">850 mg three times daily for 19 doses<footnote id="table1-ft-e">Kinetic study done following dose 19, given fasting</footnote> (9)</td><td stylecode="Lrule">2.01 (±0.42)</td><td stylecode="Lrule">1.79 (±0.94)</td><td stylecode="Lrule Rrule">642 (±173)</td></tr>
<tr><td stylecode="Lrule"><content stylecode="bold">Adults with type 2 diabetes:</content></td><td stylecode="Lrule"></td><td stylecode="Lrule"></td><td stylecode="Lrule Rrule"></td></tr>
<tr><td stylecode="Lrule">850 mg single dose (23)</td><td stylecode="Lrule">1.48 (±0.5)</td><td stylecode="Lrule Rrule">3.32 (±1.08)</td><td stylecode="Lrule Rrule">491 (±138)</td></tr>
<tr stylecode="Botrule"><td stylecode="Lrule">850 mg three times daily for 19 doses<footnoteref idref="table1-ft-e"></footnoteref> (9)</td><td stylecode="Lrule">1.90 (±0.62)</td><td stylecode="Lrule">2.01 (±1.22)</td><td stylecode="Lrule Rrule">550 (±160)</td></tr>
<tr><td stylecode="Lrule"><content stylecode="bold">Elderly<footnote>Elderly subjects, mean age 71 years (range 65-81 years)</footnote> ,healthy nondiabetic adults:</content></td><td stylecode="Lrule"></td><td stylecode="Lrule"></td><td stylecode="Lrule Rrule"></td></tr>
<tr stylecode="Botrule"><td stylecode="Lrule">850 mg single dose (12)</td><td stylecode="Lrule">2.45 (±0.70)</td><td stylecode="Lrule">2.71 (±1.05)</td><td stylecode="Lrule Rrule">412 (±98)</td></tr>
<tr><td stylecode="Lrule"><content stylecode="bold">Renal-impaired adults:<br/>850 mg single dose</content></td><td stylecode="Lrule"></td><td stylecode="Lrule"></td><td stylecode="Lrule Rrule"></td></tr>
<tr><td stylecode="Lrule"><content stylecode="bold">Mild</content>(CL<sub>cr</sub><footnote>CL<sub>cr</sub>= creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup></footnote> 61-90 mL/min) (5)</td><td stylecode="Lrule">1.86 (±0.52)</td><td stylecode="Lrule">3.20 (±0.45)</td><td stylecode="Lrule Rrule">384 (±122)</td></tr>
<tr><td stylecode="Lrule"><content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/min) (4)</td><td stylecode="Lrule">4.12 (±1.83)</td><td stylecode="Lrule">3.75 (±0.50)</td><td stylecode="Lrule Rrule">108 (±57)</td></tr>
<tr><td stylecode="Lrule"><content stylecode="bold">Severe</content>(CL<sub>cr</sub>10-30 mL/min) (6)</td><td stylecode="Lrule">3.93 (±0.92)</td><td stylecode="Lrule">4.01 (±1.10)</td><td stylecode="Lrule Rrule">130 (±90)</td></tr>
</tbody>
</table>